心肌梗死后个体化医疗的计算建模进展
心肌梗死是全球早发疾病和死亡的主要原因,确定急性心梗后哪些患者会出现心衰和心源性猝死对临床医生来说非常困难。心脏影像(超声心动图或心脏磁共振)可提供复杂数据集,但日常实践中仅被部分利用,提示风险分层有改进空间。左心室功能的计算建模可弥合基于心脏影像的个体化医疗差距,多种新型生物力学参数具有理论预后价值,但临床转化面临模型不确定性、验证与确认以及高效处理等挑战。
要点
- 心梗后心衰和心源性猝死的风险分层困难,心脏影像数据未被充分利用。
- 左心室计算建模可提供心肌收缩力、硬度和应力等生物力学参数。
- 这些参数有理论预后价值,但临床转化需解决模型不确定性和验证问题。
核心结论
- 左心室功能计算建模有望利用心脏影像数据推动心梗后个体化医疗。
- 新型生物力学参数具有理论预后价值,但需进一步研究和验证才能临床转化。
研究设计与样本
- 综述性文章,讨论心肌梗死后计算建模的进展与挑战。
主要发现
- 心脏影像(超声或心脏磁共振)提供的数据集在临床实践中仅被部分利用。
- 计算建模可得出心肌收缩力(区域和整体)、硬度和应力等生物力学参数。
- 这些参数可在空间上与梗死病理和远端区域对应。
临床怎么用
- 计算建模参数有望用于心梗后不良重构的预防治疗评估和风险分层。
- 临床转化需要简化心脏磁共振成像、验证生物力学参数与 established 预后标志物(如左室射血分数和梗死面积)的关系。
- 需要用户交互最少的可及软件包,并通过多学科合作实现患者获益。
局限性
- 模型存在不确定性。
- 需要验证与确认。
- 需要高效的时间处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myocardial infarction (MI) is a leading cause of premature morbidity and mortality worldwide. Determining which patients will experience heart failure and sudden cardiac death after an acute MI is notoriously difficult for clinicians. The extent of heart damage after an acute MI is informed by cardiac imaging, typically using echocardiography or sometimes, cardiac magnetic resonance (CMR). These scans provide complex data sets that are only partially exploited by clinicians in daily practice, implying potential for improved risk assessment. Computational modelling of left ventricular (LV) function can bridge the gap towards personalised medicine using cardiac imaging in patients with post-MI. Several novel biomechanical parameters have theoretical prognostic value and may be useful to reflect the biomechanical effects of novel preventive therapy for adverse remodelling post-MI. These parameters include myocardial contractility (regional and global), stiffness and stress. Further, the parameters can be delineated spatially to correspond with infarct pathology and the remote zone. While these parameters hold promise, there are challenges for translating MI modelling into clinical practice, including model uncertainty, validation and verification, as well as time-efficient processing. More research is needed to (1) simplify imaging with CMR in patients with post-MI, while preserving diagnostic accuracy and patient tolerance (2) to assess and validate novel biomechanical parameters against established prognostic biomarkers, such as LV ejection fraction and infarct size. Accessible software packages with minimal user interaction are also needed. Translating benefits to patients will be achieved through a multidisciplinary approach including clinicians, mathematicians, statisticians and industry partners.
引用
- Mangion K, Gao H, Husmeier D, et al. Advances in computational modelling for personalised medicine after myocardial infarction. Heart. 2017. PMID: 29127185. doi:10.1136/heartjnl-2017-311449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。